A Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
Multiple locations, including Dothan
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
Multiple locations, including DothanThis study is recruiting in Bosnia and Herzegovina. It focuses on Anxiety.
In Bosnia and HerzegovinaThis study is recruiting in Colombia. It focuses on Bipolarity.
In ColombiaThis study is recruiting in Pakistan. It focuses on Anxiety.
In PakistanThis study is recruiting in Pakistan. It focuses on Anxiety.
In PakistanThis study is recruiting in Peru. It focuses on Bipolarity.
In PeruThis study is recruiting in Uganda. It focuses on Schizophrenia.
In UgandaThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It is testing group Cognitive Behaviour Therapy for depression.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Depression.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Depression.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Depression.
In United Kingdom